Sartorius Stedim Biotech S.A. (0RG8.IL)
IOB - IOB Delayed price. Currency in EUR
Add to watchlist
As of 08:36AM GMT. Market open.
| Previous close | 304.60 |
| Open | 307.20 |
| Bid | 298.30 x 0 |
| Ask | 313.50 x 0 |
| Day's range | 303.00 - 307.20 |
| 52-week range | 269.40 - 399.90 |
| Volume | |
| Avg. volume | 39,526 |
| Market cap | 27.927B |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | 53.33 |
| EPS (TTM) | 5.68 |
| Earnings date | N/A |
| Forward dividend & yield | 1.26 (0.36%) |
| Ex-dividend date | 31 Mar 2022 |
| 1y target est | N/A |
- Reuters
Sartorius confirms 2022 revenues target
Franco-German lab supplies maker Sartorius said on Thursday that 2022 full-year sales were on target but predicted growth in 2023 would not be as strong amid demand normalization and further declines in the COVID-19-related business. Sales growth rose by 15% in constant currencies, according to preliminary figures, Sartorius said. In October, Sartorius predicted consolidated 2022 sales revenue growth would be in the lower half of the range of around 15% to 19%.
© 2023 Yahoo. All rights reserved.
